Investigating how a specific protein interacts with others to affect sugar modifications in cells

Understanding the mechanism of adaptor protein engagement by OGT and its functional effects on glycosylation

NIH-funded research St. Olaf College · NIH-10797591

This study is looking at how a special enzyme called OGT adds sugar molecules to proteins, which is important for keeping our cells healthy, and it hopes to find new ways to help treat diseases like Alzheimer's and cancer where this process goes wrong.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionSt. Olaf College NIH-funded
Lab location1 site (Northfield, United States)
Project IDNIH-10797591 on NIH RePORTER

What this research studies

This research focuses on understanding how the O-GlcNAc transferase (OGT) enzyme interacts with various proteins to modify them with sugar molecules, which is crucial for many cellular functions. By studying the mechanisms of how OGT selects its protein substrates, the research aims to uncover potential therapeutic strategies for diseases like Alzheimer's and cancer, where these modifications are disrupted. The approach involves detailed biochemical assays to analyze protein interactions and modifications in both the nucleus and cytoplasm of cells.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias.

Not a fit: Patients with non-neurological conditions or those not diagnosed with Alzheimer's or related dementias may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease and other conditions linked to protein misregulation.

How similar studies have performed: While the specific mechanisms of OGT substrate selection are still being explored, similar research has shown promise in understanding protein modifications and their implications in various diseases.

Where this research is happening

Northfield, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.